Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP20905.RA_eOQAr34_r3EaiwEOtLY_fUUPEZlgIxiebqtiLEL_cs130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20905.RA_eOQAr34_r3EaiwEOtLY_fUUPEZlgIxiebqtiLEL_cs130_provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP20231.RAnr3-iQDH9DCcq_ookg82jJlh5ASG7iR4PJw3Gqv9vHg130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20231.RAnr3-iQDH9DCcq_ookg82jJlh5ASG7iR4PJw3Gqv9vHg130_provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP830715.RAAKLahdlMw7qnUb-DPTIGxVs_2h-Z9-0_ATE96NTFBBk130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830715.RAAKLahdlMw7qnUb-DPTIGxVs_2h-Z9-0_ATE96NTFBBk130_provenance.
• NP687028.RAdTzEHNJalfwsAFEfweV9pxccs6TV7AbTIviK0JtNfPI130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687028.RAdTzEHNJalfwsAFEfweV9pxccs6TV7AbTIviK0JtNfPI130_provenance.
• NP589288.RABMGAqAaI1fsYroumkUmwY_HiF9Ujn3zyKgOZdaDkhOw130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589288.RABMGAqAaI1fsYroumkUmwY_HiF9Ujn3zyKgOZdaDkhOw130_provenance.
• NP416498.RAoK7eoDSzmoiJyJN1I_OsU5eYo5diEq5m6_H1hivM5V4130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416498.RAoK7eoDSzmoiJyJN1I_OsU5eYo5diEq5m6_H1hivM5V4130_provenance.
• NP589304.RAiOaHUufN4vJrhN9M0D09hwlrSGU2SEBmkTg9gPEGX0g130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589304.RAiOaHUufN4vJrhN9M0D09hwlrSGU2SEBmkTg9gPEGX0g130_provenance.
• NP687027.RAtem4TGJ9bwJDnSX1n6Ry-uCInKS9h97sWzWrVoKoX1M130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687027.RAtem4TGJ9bwJDnSX1n6Ry-uCInKS9h97sWzWrVoKoX1M130_provenance.
• NP687035.RAlfrFp6fJhEIaIWC6ufNXw8grrflp9ns5fwLWk1ZIR2k130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687035.RAlfrFp6fJhEIaIWC6ufNXw8grrflp9ns5fwLWk1ZIR2k130_provenance.
• NP416489.RA2sk-9JyyYPOp8mMpqEJwgQv9Ux6T4YLKwxgO-4pAj5o130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416489.RA2sk-9JyyYPOp8mMpqEJwgQv9Ux6T4YLKwxgO-4pAj5o130_provenance.
• NP687032.RAJNwinGPT89MQB0ECTyLaxUrX0HBaIc-RZ9G7xFPMGN0130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687032.RAJNwinGPT89MQB0ECTyLaxUrX0HBaIc-RZ9G7xFPMGN0130_provenance.
• NP687037.RANAMQfZdsTv0GeBCDhO5QjAjadLYkbl1sD6epd2cVOxY130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687037.RANAMQfZdsTv0GeBCDhO5QjAjadLYkbl1sD6epd2cVOxY130_provenance.
• NP830718.RAPTwVH-_i5SMkEFAwWluG5kN5hq67CXOPQR-YN5qddbM130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830718.RAPTwVH-_i5SMkEFAwWluG5kN5hq67CXOPQR-YN5qddbM130_provenance.
• NP687031.RA5GZ0WWL-D5sEbKS3IlmnyAxYPP8XONwvQu8p-Zj6HRY130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687031.RA5GZ0WWL-D5sEbKS3IlmnyAxYPP8XONwvQu8p-Zj6HRY130_provenance.
• NP22331.RA6IOx7kmWtXLqzUJQAYP3O51fKBhz3a5dzSxEWaBVU9U130_assertion description "[Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22331.RA6IOx7kmWtXLqzUJQAYP3O51fKBhz3a5dzSxEWaBVU9U130_provenance.